Skip to main content

Day: January 24, 2024

Barbara A. Romano Promoted to First Woman CIO at SJI

Leonard Brinson Jr. Announces Retirement FOLSOM, NJ, Jan. 24, 2024 (GLOBE NEWSWIRE) — Barbara A. Romano Promoted to First Woman CIO at SJILeonard Brinson Jr. Announces Retirement FOLSOM, NJ, January 24, 2024 – SJI announced today that Barbara A. Romano has been promoted to chief information officer, replacing Leonard Brinson Jr., who is retiring at the end of the month. Romano, who previously served as SJI’s vice present for technology and operations, becomes the first woman to take on the CIO role at the utility holding company that provides natural gas to more than 725,000 customers in New Jersey. “I am both honored and excited to break through barriers and pave the way for more women in leadership roles,” Romano said. “My goal is not only to navigate the currents of information technology but to empower our teams, foster collaboration,...

Continue reading

Silo Pharma Announces Positive Results in Alzheimer’s Disease Study

Preclinical study shows SPC-14’s effectiveness against LH (luteinizing hormone) stress, helplessness, and anxiety. SARASOTA, FL, Jan. 24, 2024 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or “the Company”), a biopharmaceutical company developing novel formulations and drug delivery systems for traditional therapeutics and psychedelic treatments, today announced that its Alzheimer’s disease therapeutic SPC-14 showed positive efficacy in small animals. Data from a study conducted at Columbia University in collaboration with Silo Pharma showed that SPC-14 was effective against LH stress in attenuating learned helplessness, perseverative behavior, and hyponeophagia (a measure of anxiety). The mice were treated twice daily with the SPC-14 therapeutic. “We believe that today’s announcement, along with our past studies...

Continue reading

Arhaus Unveils Spring 2024 Collection

Exploring the rich narratives found within every corner of the home, ‘A Story Unfolding’ exclusively reveals decades-long tales of artistry, tradition and enduring partnerships rooted in craftsmanshipArhaus Spring 2024 CollectionArhaus Spring 2024 CollectionBOSTON HEIGHTS, Ohio, Jan. 24, 2024 (GLOBE NEWSWIRE) — Arhaus (NASDAQ: ARHS), a leader in artisan-crafted and responsibly sourced home furnishings, debuts its Spring 2024 Collection, ‘A Story Unfolding.’ Presenting luxurious Italian upholstery introductions and collection expansions, a relaunch of its bedding assortment, and a celebration of materials, time-honored techniques, and artisan roots, ‘A Story Unfolding’ treasures the memories of home while inspiring those to come. The complete Spring 2024 Collection is now available online at Arhaus.com and in more than...

Continue reading

BTCS Issues Shareholder Letter Reflecting on 2023 and Outlook for 2024

Builder+Builder+ChainQChainQStakeSeekerStakeSeekerFair Value of Crypto and Cash $26.7 Million as of December 31, 2023 Over $6m in Net Income expected for 2023 through early adoption of new accounting rules Silver Spring, MD, Jan. 24, 2024 (GLOBE NEWSWIRE) — BTCS Inc. (Nasdaq: BTCS) (“BTCS” or the “Company”), a blockchain technology-focused company, issued a letter to its shareholders describing the Company’s recent achievements and goals for 2024. The letter from Charles Allen, CEO of BTCS, is reprinted below in its entirety. Dear Shareholders, As we look back on the past year and anticipate the opportunities of 2024, I am pleased to share this annual letter with all of you, our valued shareholders who have steadfastly supported BTCS Inc. Ending the Year on a High NoteOur strategic decisions paid off...

Continue reading

Altamira Therapeutics Files Second Provisional Patent Application for OligoPhore Nanoparticles Targeting Different KRAS Mutations in Cancer Treatment

HAMILTON, BERMUDA, Jan. 24, 2024 (GLOBE NEWSWIRE) —Altamira’s polyKRASmut siRNA shown to knock down at least 65-91% of KRAS mutations in colorectal, non-small cell lung, and pancreatic cancer cell lines Fresh experimental data expected to strengthen Altamira’s intellectual property around its AM-401 nanoparticles for the treatment of KRAS-driven cancersHAMILTON, BERMUDA, Jan. 24, 2024 — Altamira Therapeutics Ltd. (Nasdaq: CYTO) (“Altamira” or the “Company”), a company providing nanoparticle-based technology for efficient RNA delivery to extrahepatic targets, today announced that it has filed a second provisional patent application with the United States Patent and Trade Office (USPTO) to provide broad coverage of different KRAS mutations in human cancer treatment with nanoparticles comprising...

Continue reading

HomeTrust Bancshares, Inc. Announces Financial Results for the Second Quarter of the Six-Month Transition Period Ending December 31, 2023* and Quarterly Dividend

ASHEVILLE, N.C., Jan. 24, 2024 (GLOBE NEWSWIRE) — HomeTrust Bancshares, Inc. (NASDAQ: HTBI) (“Company”), the holding company of HomeTrust Bank (“Bank”), today announced preliminary net income for the second quarter of the six-month transition period ended December 31, 2023* and approval of its quarterly cash dividend. For the quarter ended December 31, 2023 compared to the quarter ended September 30, 2023:net income was $13.5 million compared to $14.8 million; diluted earnings per share (“EPS”) was $0.79 compared to $0.88; annualized return on assets (“ROA”) was 1.21% compared to 1.33%; annualized return on equity (“ROE”) was 10.81% compared to 12.23%; net interest income was $41.9 million compared to $42.2 million; net interest margin was 4.02% for both periods; provision...

Continue reading

Cleanroom Technology Market Set to Soar Past USD 5.6 Billion by 2030

The global Cleanroom Technology market size is expected to reach USD 5.6 billion by 2030 and exhibit a CAGR of 5.58% in the forecast period (2023−2030), according to Skyquest’s latest research report. The stringent regulatory requirements in industries such as pharmaceuticals and healthcare, the increasing demand for contamination-free environments in semiconductor and electronics manufacturing, a growing focus on research and development activities in life sciences, biotechnology, and nanotechnology, the rising awareness of the importance of infection control in healthcare settings, and the expansion of the aerospace and automotive manufacturing sectors, which require controlled environments for quality assurance is fueling the market’s growth. Westford USA, Jan. 24, 2024 (GLOBE NEWSWIRE) — According to SkyQuest’s...

Continue reading

AGF Management Limited Reports Fourth Quarter and Fiscal Year 2023 Financial Results

TORONTO, Jan. 24, 2024 (GLOBE NEWSWIRE) —Reported quarterly adjusted diluted earnings per share of $0.28 Total assets under management and fee-earning assets of $42.2 billion Growth of 18.5% in ETFs and SMA AUM year over year Quarterly dividend of $0.11 per shareAGF Management Limited (AGF or the Company) (TSX: AGF.B) today announced financial results for the fourth quarter and fiscal year ended November 30, 2023. AGF reported total assets under management and fee-earning assets1 of $42.2 billion compared to $42.3 billion as at August 31, 2023 and $41.8 billion as at November 30, 2022. “In a year characterized by challenging business and market conditions, we demonstrated our resilience and continued to execute on our long-term plan to diversify our business across asset classes and client channels, giving us the stability...

Continue reading

National Bankshares, Inc. Announces Agreement to Acquire Frontier Community Bank

BLACKSBURG, Va. and WAYNESBORO, Va., Jan. 24, 2024 (GLOBE NEWSWIRE) — National Bankshares, Inc. (“National Bankshares” or the “Company”) (Nasdaq: NKSH) and Frontier Community Bank (“Frontier”) jointly announced today that they have entered into a definitive merger agreement for National Bankshares to acquire Frontier. As of September 30, 2023, Frontier had total assets of approximately $154 million. Upon completion of the transaction, National Bankshares is expected to have total consolidated assets of approximately $1.7 billion based on September 30, 2023 financial data. “We are pleased to announce our partnership with Frontier Community Bank, and we believe that our compatible cultures and shared values will enhance our position as a true Virginia community bank,” said Brad Denardo, Chairman, President and CEO of National Bankshares....

Continue reading

Blue Foundry Bancorp Reports Fourth Quarter and Year-End 2023 Results

RUTHERFORD, N.J., Jan. 24, 2024 (GLOBE NEWSWIRE) — Blue Foundry Bancorp (NASDAQ:BLFY) (the “Company”), the holding company for Blue Foundry Bank (the “Bank”), today reported a net loss of $7.4 million, or $0.31 per diluted common share, for the year ended December 31, 2023 compared to net income of $2.4 million, or $0.09 per diluted common share for the year ended December 31, 2022. The Company reported a net loss of $2.9 million, or $0.13 per diluted common share, for the three months ended December 31, 2023 compared to a net loss of $1.4 million, or $0.06 per diluted common share for the three months ended September 30, 2023, and net income of $562 thousand, or $0.02 per diluted common share for the three months ended December 31, 2022. James D. Nesci, President and Chief Executive Officer, commented, “2023 proved to be a challenging...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.